A Case of Less Common Mycosis
Authors:
I. Lomicová; M. Novák; P. Cetkovská; K. Pizinger
Authors‘ workplace:
Dermatovenerologická klinika LF UK a FN Plzeň
přednosta prof. MUDr. Karel Pizinger, CSc.
Published in:
Čes-slov Derm, 91, 2016, No. 5, p. 238-240
Category:
Case Reports
Overview
Trichophyton tonsurans is an anthropophilic dermatophyte with worldwide distribution. Whereas it is a leading cause of tinea capitis in the North America, infections with Trichophyton tonsurans appear relatively rarely on the European continent. Although Trichophyton tonsurans is primarily associated with tinea capitis, it can also cause tinea corporis, especially among sportsmen. The authors describe the case of a 40-year old patient with an atypically extensive clinical picture caused by Trichophyton tonsurans infection. Therapy with terbinafin in dose of 250 mg /day perorally for three weeks and with topical antimycotics for 6 weeks cured the lesions.
Key words:
tinea – Trichophyton tonsurans – terbinafin
Sources
1. BABIĆ-ERCEG, A., BARISIĆ, Z., ERCEG, M., BABIĆ, A., BORZIĆ, E., ZORANIĆ, V. et al. Dermatophytoses in Split and Dalmatia, Croatia, 1996–2002. Mycoses, 2004, 47, p. 297–299.
2. BRAUN-FALCO, O., BURGDORF, W. H. C. Braun-Falco‘s dermatology. Heidelberg: Springer, 2009, p. 213–216.
3. FOSTER, K. V., GHANNOUM, M. A., ELEWSKI, B. E. Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002. J. Am. Acad. Dermatol., 2004, 50, p. 748–752.
4. FULLER, L. C. Changing face of tinea capitis in Europe. Curr. Opin Infect. Dis., 2009, 22, p. 115–118.
5. HEDAYATI, M. T., AFSHAR, P., SHOKOHI, T., AGHILI, R. A study on tinea gladiatorum in young wrestlers and dermatophyte contamination of wrestling mats from Sari, Iran. Br. J. Sports Med., 2007, 41, p. 332–334.
6. HIROSE, N., SUGANAMI, M., SHIRAKI, Y., HIRUMA, M., OGAWA, H. Management and follow-up survey of Trichophyton tonsurans infection in a university judo club. Mycoses, 2008, 51, p. 243–247.
7. HIRUMA, J., OGAWA, Y., HIRUMA, M. Trichophyton tonsurans infection in Japan: epidemiology, clinical features, diagnosis and infection control. J. Dermatol., 2015, 42, p. 245–249.
8. HRYNCEWICZ-GWÓŹDŹ, A., BECK-JENDROSCHEK, V., BRASCH, J., KALINOWSKA, K., JAGIELSKI, T. Tinea capitis and tinea corporis with a severe inflammatory response due to Trichophyton tonsurans. Acta Derm. Venereol., 2011, 91, p. 708–710.
9. HUBKA, V., ČMOKOVÁ, A., SKOŘEPOVÁ, M., MALLÁTOVÁ, N., DOBIÁŠOVÁ, S. et al. Současný vývoj v taxonomii dermatofytů a doporučení pro pojmenování klinicky významných druhů. Čes.-slov. Derm., 2014, 89, 4, p. 151–162.
10. HUBKA, V., VĚTROVSKÝ, T., DOBIÁŠOVÁ, S. et al. Molekulární epidemiologie dermatofytóz v České republice: výsledky dvouleté studie. Čes.-slov. Derm., 2014, 89, 4, p. 167–174.
11. NENOFF, P., KRÜGER, C., GINTER-HANSELMAYER, G., TIETZ, H. J. Mycology – an update. Part 1: Dermatomycoses: causative agents, epidemiology and pathogenesis. J. Dtsch. Dermatol. Ges., 2014,12, p. 188–209.
12. POISSIN, D. M., ROUSSEAU, D., DEFO, D., ESTÉVE, E. Outbreak of tinea corporis gladiatorum, a fungal skin infection due to Trichophyton tonsurans, in a French high level judo team. Euro Surveill., 2005, 10, p. 187–190.
13. SKOŘEPOVÁ, M. Dermatomykologie v obrazech. Praha: Galén, 2008, s. 19–20, 39–40.
14. ŠTORK, J. et al. Dermatovenerologie. Praha: Galén Karolinum, 2008, s. 73.
15. WELSH, O., WELSH, E., OCAMPON-CANDINI, J., GOMEZ, M., VERA-CABRERA, L. Dermatophytoses in Monterrey, México. Mycoses, 2006, 49, p. 119–123.
16. WHITE, J. M., HIGGINS, E. M., FULLER, L. C. Screening for asymptomatic carriage of Trichophyton tonsurans in household contacts of patients with tinea capitis: results of 209 patients from South London. J. Eur. Acad. Dermatol. Venereol., 2007, 21, p. 1061–1064.
Labels
Dermatology & STDs Paediatric dermatology & STDsArticle was published in
Czech-Slovak Dermatology
2016 Issue 5
Most read in this issue
-
Kontaktní dermatitidy – část II:
epikutánní testy v současné praxi - Atypical Fibroxanthoma. Case report
- A Case of Less Common Mycosis
- Analysis of Patients with Moderate to Severe Psoriasis before Starting Biologic Therapy in the Czech Republic – Data from BIOREP Registry 2005 – 2016